Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_provenance.
- NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_assertion description "[Using a new monoclonal antibody (ALK1) that recognizes the native anaplastic lymphoma kinase (ALK) protein as well as the fusion product of the t(2;5)(p23;q35), nucleophosmin (NPM)/ALK, we investigated for ALK expression cases diagnosed as ALCL as well as lympho-proliferative disorders possessing overlapping features with ALCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_provenance.
- NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_assertion evidence source_evidence_literature NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_provenance.
- NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_assertion SIO_000772 9250148 NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_provenance.
- NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_assertion wasDerivedFrom befree-20140225 NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_provenance.
- NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_assertion wasGeneratedBy ECO_0000203 NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP286355.RAg0lUuom-EreliCYJe3J7VLUn82l012F_Zb9MBRuaZwM130_provenance.